SGTX Annual Cash & Cash Equivalents
$42.07 M
-$65.08 M-60.74%
31 December 2022
Summary:
As of January 20, 2025, SGTX annual cash & cash equivalents is $42.07 million, with the most recent change of -$65.08 million (-60.74%) on December 31, 2022. During the last 3 years, it has fallen by -$34.00 million (-44.70%).SGTX Cash And Cash Equivalents Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
SGTX Quarterly Cash And Cash Equivalents
$19.62 M
-$21.63 M-52.44%
30 June 2023
Summary:
As of January 20, 2025, SGTX quarterly cash and cash equivalents is $19.62 million, with the most recent change of -$21.63 million (-52.44%) on June 30, 2023. Over the past year, it has dropped by -$14.92 million (-43.20%).SGTX Quarterly Cash And Cash Equivalents Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
SGTX Cash And Cash Equivalents Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | -60.7% | -43.2% |
| 3 y3 years | -44.7% | - |
| 5 y5 years | -34.4% | -74.2% |
SGTX Cash And Cash Equivalents High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | ||||
| 5 y | 5-year | ||||
| alltime | all time | -79.2% | -90.3% |
Sigilon Therapeutics Cash And Cash Equivalents History
| Date | Annual | Quarterly |
|---|---|---|
| June 2023 | - | $19.62 M(-52.4%) |
| Mar 2023 | - | $41.26 M(-1.9%) |
| Dec 2022 | $42.07 M(-60.7%) | $42.07 M(+27.8%) |
| Sept 2022 | - | $32.92 M(-4.7%) |
| June 2022 | - | $34.55 M(-46.4%) |
| Mar 2022 | - | $64.49 M(-39.8%) |
| Dec 2021 | $107.14 M | $107.14 M(-23.7%) |
| Date | Annual | Quarterly |
|---|---|---|
| Sept 2021 | - | $140.39 M(-13.6%) |
| June 2021 | - | $162.41 M(-9.2%) |
| Mar 2021 | - | $178.79 M(-11.6%) |
| Dec 2020 | $202.23 M(+165.8%) | $202.23 M(+222.8%) |
| Sept 2020 | - | $62.64 M(-17.7%) |
| Dec 2019 | $76.07 M(+18.7%) | $76.07 M |
| Dec 2018 | $64.10 M | - |
FAQ
- What is Sigilon Therapeutics annual cash & cash equivalents?
- What is the all time high annual cash & cash equivalents for Sigilon Therapeutics?
- What is Sigilon Therapeutics annual cash & cash equivalents year-on-year change?
- What is Sigilon Therapeutics quarterly cash and cash equivalents?
- What is the all time high quarterly cash and cash equivalents for Sigilon Therapeutics?
- What is Sigilon Therapeutics quarterly cash and cash equivalents year-on-year change?
What is Sigilon Therapeutics annual cash & cash equivalents?
The current annual cash & cash equivalents of SGTX is $42.07 M
What is the all time high annual cash & cash equivalents for Sigilon Therapeutics?
Sigilon Therapeutics all-time high annual cash & cash equivalents is $202.23 M
What is Sigilon Therapeutics annual cash & cash equivalents year-on-year change?
Over the past year, SGTX annual cash & cash equivalents has changed by -$65.08 M (-60.74%)
What is Sigilon Therapeutics quarterly cash and cash equivalents?
The current quarterly cash and cash equivalents of SGTX is $19.62 M
What is the all time high quarterly cash and cash equivalents for Sigilon Therapeutics?
Sigilon Therapeutics all-time high quarterly cash and cash equivalents is $202.23 M
What is Sigilon Therapeutics quarterly cash and cash equivalents year-on-year change?
Over the past year, SGTX quarterly cash and cash equivalents has changed by -$14.92 M (-43.20%)